Intravitreal sirolimus resolves vitreous haze in SAKURA study 1

LAS VEGAS — Intravitreal sirolimus may significantly resolve vitreous haze in patients with no anterior segment involvement, according to a presentation here. Pravin U. Dugel, MD, presented double-masked data of vitreous haze scores and steroid tapering success results of 347 patients with noninfectious uveitis of the posterior segment from month 5 of the SAKURA study 1 post hoc analysis at the American Academy of Ophthalmology annual meeting.